Literature DB >> 7691891

Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages.

J Mathison1, E Wolfson, S Steinemann, P Tobias, R Ulevitch.   

Abstract

Exposure of rabbit peritoneal exudate macrophages (PEM) or whole blood to picomolar concentrations of LPS induces adaptation or hyporesponsiveness to LPS. Because of the importance of plasma LPS-binding protein (LBP) and the macrophage cell membrane protein CD14 in recognition of LPS, we examined the effect of LBP on LPS-induced adaptation in PEM. PEM exposed to LPS in the presence of LBP for 8 h were markedly less responsive to subsequent stimulation by LPS than monocytes/macrophages (M phi) adapted in the absence of LBP. LPS-induced expression of TNF was sharply reduced in LBP-LPS-adapted PEM, but in contrast these cells remained fully responsive to Staphylococcus aureus peptidoglycan. We considered that specific hyporesponsiveness in LPS-adapted M phi or in blood monocytes could be due to decreased expression of CD14 or diminished binding of LBP-LPS complexes to CD14. However, flow cytometry analysis revealed only minimal reduction of CD14 expression or CD14-dependent binding of a fluorescent LPS derivative when normo- and hyporesponsive cells were compared. These results show that complexes of LPS and LBP are more effective than LPS alone in inducing adaptation to LPS, and LPS-induced hyporesponsiveness probably results from changes in cellular elements distinct from CD14 that are involved in either LPS recognition or LPS-specific signal transduction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691891      PMCID: PMC288374          DOI: 10.1172/JCI116801

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking.

Authors:  R Dziarski
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

2.  Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.

Authors:  J C Mathison; P S Tobias; E Wolfson; R J Ulevitch
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

3.  Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level.

Authors:  S H Zuckerman; G F Evans
Journal:  Cell Immunol       Date:  1992-04       Impact factor: 4.868

4.  Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.

Authors:  R L Kitchens; R J Ulevitch; R S Munford
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

5.  Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein.

Authors:  S B Corradin; J Mauël; P Gallay; D Heumann; R J Ulevitch; P S Tobias
Journal:  J Leukoc Biol       Date:  1992-10       Impact factor: 4.962

6.  Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.

Authors:  T R Martin; J C Mathison; P S Tobias; D J Letúrcq; A M Moriarty; R J Maunder; R J Ulevitch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.

Authors:  D Heumann; P Gallay; C Barras; P Zaech; R J Ulevitch; P S Tobias; M P Glauser; J D Baumgartner
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

8.  Lipopolysaccharide-dependent and lipopolysaccharide-independent pathways of monocyte desensitisation to lipopolysaccharides.

Authors:  A Y Annenkov; F S Baranova
Journal:  J Leukoc Biol       Date:  1991-09       Impact factor: 4.962

9.  Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.

Authors:  M J Pabst; H B Hedegaard; R B Johnston
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  J D Lee; K Kato; P S Tobias; T N Kirkland; R J Ulevitch
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  17 in total

1.  Analysis of the CD14 receptor associated with bovine alveolar macrophages.

Authors:  Z Yang; G L Mason; D O Slauson; P N Bochsler
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

2.  A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes.

Authors:  M Kreutz; U Ackermann; S Hauschildt; S W Krause; D Riedel; W Bessler; R Andreesen
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

3.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

Authors:  D M Underhill; A Ozinsky; K D Smith; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression.

Authors:  S Kastenbauer; H W Ziegler-Heitbrock
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxin.

Authors:  D Heumann; Y Adachi; D Le Roy; N Ohno; T Yadomae; M P Glauser; T Calandra
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 6.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

7.  Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.

Authors:  N Hirohashi; D C Morrison
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Acute pulmonary lipopolysaccharide tolerance decreases TNF-alpha without reducing neutrophil recruitment.

Authors:  Sudha Natarajan; Jiyoun Kim; Daniel G Remick
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum.

Authors:  J M Prins; E J Kuijper; M L Mevissen; P Speelman; S J van Deventer
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

10.  Chronic pulmonary LPS tolerance induces selective immunosuppression while maintaining the neutrophilic response.

Authors:  Sudha Natarajan; Jiyoun Kim; Daniel G Remick
Journal:  Shock       Date:  2010-02       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.